Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Sulfacetamide sodium 100mg, prednisolone sodium phosphate 2.5mg; per mL; contains thimersol.
Various generic manufacturers
Indications for Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution:
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
Adults and Children:
<6yrs: not established. ≥6yrs: instill 2 drops in the eye(s) every 4 hours. Max initial ℞: 20mL.
Ocular fungal, viral or mycobacterial infections.
Do not inject into the eye. Corneal or scleral thinning. Severe dry eye. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Reevaluate if symptoms fail to improve after two days. Pregnancy (Cat.C). Nursing mothers: not recommended.
Incompatible with silver preparations. Local anesthetics related to p-aminobenzoic acid may antagonize the action of sulfonamide.
Antibacterial + steroid.
Local irritation, sensitization, masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.
Formerly known under the brand name Vasocidin.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA Fast-Tracks Treatment for Autism Spectrum Disorder
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics